Welcome to our dedicated page for NuSkin Enterprises news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on NuSkin Enterprises stock.
Nu Skin Enterprises, Inc. (NYSE: NUS) is a global leader in health and beauty, founded 35 years ago. The company excels in creating and distributing innovative consumer products, focusing on beauty and wellness. Nu Skin’s product lines include personal care items under the Nu Skin brand and nutritional supplements marketed under the Pharmanex brand. Operating in more than 50 countries, the firm’s extensive reach reflects its robust international presence.
Nu Skin Enterprises encompasses several companies such as Nu Skin, Groviv, Wasatch Labs, Elevate Health Sciences, and Casepak. This diverse portfolio enables the company to offer a wide range of products and services, from consumer goods to advanced manufacturing and controlled environment agriculture technologies.
In recent developments, Nu Skin has shown a commitment to innovation and growth. In October 2023, the company announced the release of its third quarter financial results, revealing both challenges and growth opportunities. Despite economic hurdles, particularly in Mainland China and the Americas, Nu Skin experienced stabilization and growth in regions like Europe and Africa. The introduction of new products, such as the ageLOC® WellSpa iO™ and an upcoming mental wellness category in 2024, showcases the firm’s dedication to expanding its offerings and driving long-term success.
In November 2023, Nu Skin celebrated the opening of a new manufacturing facility in Shanghai, China, an investment of approximately $55 million. This facility exemplifies the company's commitment to enhancing production capacity and supply chain efficiency, particularly in Asian markets. The plant uses Industry 4.0 standards, featuring smart systems and real-time data analysis, further underlining Nu Skin’s focus on technological advancement and sustainability.
Additionally, in February 2024, Nu Skin introduced the RenuSpa iO, a smart device designed to promote skin health and body confidence. This FDA-cleared device embodies the latest in microcurrent technology, offering personalized beauty and wellness solutions. The Nu Skin Vera® app enhances the user experience by providing real-time data insights and guided tutorials.
Financial Overview: As of the latest updates, Nu Skin’s projected 2023 revenue is between $1.92 and $1.96 billion, with an expected EPS of $(0.10) to $0.05 or adjusted EPS of $1.62 to $1.77, excluding significant charges. The company’s strategic initiatives, including cost management and product portfolio optimization, aim to drive future growth and profitability.
Nu Skin Enterprises (NYSE: NUS) will release its first quarter results on May 4, 2022, after market close. A conference call is scheduled for 5 p.m. ET to discuss the quarterly results and future business initiatives. The company is renowned for its beauty and wellness products, supported by over 35 years of scientific research, including brands like ageLOC and Pharmanex. Operating in around 50 markets globally, Nu Skin emphasizes sustainability and community health through its initiatives.
Nu Skin Enterprises (NYSE: NUS) has been awarded two Communitas Awards for its excellence in community service, corporate social responsibility, and environmental responsibility. Recognized for its initiatives to combat malnutrition and promote wellness for children, Nu Skin's efforts also focus on reducing its carbon footprint and expanding sustainability commitments through 2030. Chief Reputation Officer Ruth Todd emphasized the company’s dedication to enhancing its community service and environmental impact in the future.
Nu Skin Enterprises (NYSE: NUS) announced a donation of nearly $100,000 to MCE Social Capital as part of International Women's Day. The funds will support women entrepreneurs in developing countries through microloans. Since 2006, MCE has impacted over 9 million people, with 73% being women. The donation results from previous sales of the ageLOC LumiSpa device. With a focus on sustainability, this initiative aligns with Nu Skin’s mission to empower individuals and promote economic opportunities for underserved communities.
Nu Skin Enterprises reported a Q4 2021 revenue of $673.4 million, down 10% year-over-year, with an EPS of $(0.18). Annual revenue for 2021 was $2.70 billion, a 4% increase, but EPS dropped 21% to $2.86. The company projected Q1 2022 revenue between $560 million and $590 million, reflecting a 13% to 17% decline. Despite challenges in Asian markets, U.S. growth reached 32% for 2021. Looking ahead, Nu Skin aims for a revenue range of $2.66 billion to $2.77 billion for 2022, with a focus on technology investment to support affiliates.
Nu Skin Enterprises (NYSE: NUS) has announced a quarterly cash dividend increase to $0.385 per share, effective March 9, 2022, for shareholders on record by February 28, 2022. This marks the 21st consecutive year of dividend increases, reflecting the company's strong financial position and confidence in long-term earnings, according to CFO Mark Lawrence. Nu Skin's commitment also includes sustainability initiatives, aiming for reduced packaging by 2030, and it operates in about 50 markets worldwide, offering innovative beauty and wellness products.
Nu Skin Enterprises (NYSE: NUS) has announced that its investor day will take place virtually on February 16, 2022, at 10 a.m. MST, due to COVID-related safety protocols. CEO Ryan Napierski and the management team will discuss the fourth quarter and 2021 results, along with guidance for 2022. The event will highlight the company's strategies in personalized beauty and wellness products and social commerce. Results for Q4 and the full year will be released prior to the market opening on the same day.
Nu Skin Enterprises (NYSE: NUS) will hold an investor day on February 16, 2022, at 10 a.m. MST in Provo, Utah, with options for online participation. The event will feature company leadership, including President and CEO Ryan Napierski, discussing fourth quarter and full-year 2021 results, as well as 2022 financial guidance. Attendees will gain insights into Nu Skin's strategy for personalized beauty and wellness products, its social commerce model, and updates on its digital ecosystem. A replay will be available post-event until March 2, 2022.
Nu Skin's ageLOC LumiSpa has been awarded Product of the Year at the 2021 BIG Awards for Business, recognizing its superior cleansing capabilities that have positively impacted consumers. The device remains a top-seller, cementing Nu Skin's status as a leader in the at-home beauty device market for four consecutive years. This accolade adds to over 30 international awards received by ageLOC LumiSpa, underscoring its effectiveness and innovative design.
Nu Skin Enterprises (NYSE: NUS) announced a milestone of supplying 750 million meals to malnourished children globally through its Nourish the Children initiative since 2002. The initiative delivers VitaMeal, a nutrient-rich food, to kids in over 50 countries, highlighting the company’s commitment to combat childhood hunger. Nu Skin aims to provide one billion meals, reflecting ongoing efforts to address malnutrition.
FAQ
What is the current stock price of NuSkin Enterprises (NUS)?
What is the market cap of NuSkin Enterprises (NUS)?
What does Nu Skin Enterprises, Inc. do?
When was Nu Skin Enterprises, Inc. founded?
What is the ticker symbol for Nu Skin Enterprises, Inc.?
What were the recent financial results for Nu Skin Enterprises, Inc.?
What is the ageLOC® WellSpa iO™?
What is the significance of the new manufacturing facility in China for Nu Skin?
What is RenuSpa iO?
Who are the members of the Nu Skin Enterprises family?
How does Nu Skin contribute to sustainability?
What is the Nu Skin Vera® app?
